Insights
Search Results
Client Highlights
6.30.26
Wilson Sonsini Advises Cognite, Major Shareholders on $3.1 Billion Sale to Schneider Electric
On June 30, 2026, Aker ASA (Aker) and the other shareholders of Cognite announced that they have entered into an agreement to sell 100 percent of the shares in Cognite Holding B.V. (Cognite) to Schneider Electric based on an enterprise value of US$3.1 billion. Wilson Sonsini Goodrich & Rosati’s cross-border tech M&A team advised Cognite and its major shareholders, including Aker, TCV, and Accel, on the transaction.
News Articles
6.04.26
Wilson Sonsini Practices, Attorneys Recognized in 2026 Chambers USA Guide
The 2026 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 44 geography-specific practice categories and named 87 Wilson Sonsini attorneys among the best in their fields. This year, the firm received four new practice area rankings, including in the nationwide National Security and Capital Markets: Convertible Debt categories, and three improved practice area rankings.
Client Highlights
6.02.26
Wilson Sonsini Advises Contentful on Acquisition by Salesforce
On June 1, 2026, Salesforce, the world's No. 1 AI CRM, announced that it has signed a definitive agreement to acquire Contentful, a leading composable content platform trusted by over 4,800 of the world’s leading brands to deliver personalized digital experiences at scale. Wilson Sonsini Goodrich & Rosati advised Contentful on the transaction.
Client Highlights
4.29.26
Firm Advises Match Group on $100 Million Investment in Sniffies
On April 27, 2026, Match Group, a leading provider of digital technologies designed to help people make meaningful connections, announced a $100 million investment in Sniffies, a map-based platform serving non-heterosexual men. The investment represents a significant minority ownership stake and includes the option to acquire the remaining equity in the future. Sniffies will continue to operate independently and remain founder-led, with Match Group supporting the team's vision and growth. Wilson Sonsini Goodrich & Rosati advised Match Group on the transaction.
Client Highlights
3.18.26
Wilson Sonsini Advises XENOM on $15 Million Seed Round and Commercial Agreement with Rogue Fitness
On February 27, 2026, XENOM announced it has officially launched with a $15 million seed financing to create stadium-scale global events. The round was led by WndrCo and Rogue Fitness. Additionally, Rogue Fitness will serve as XENOM’s official equipment supplier. Wilson Sonsini Goodrich & Rosati advised XENOM on the transactions.
Client Highlights
2.23.26
Firm Advises Arcellx on $7.8 Billion Acquisition by Gilead
On February 23, 2026, Gilead Sciences announced that it has entered into a definitive agreement to acquire Arcellx, a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, for $115 per share in cash at closing and one contingent value right of $5 per share, which represents an implied equity value of $7.8 billion payable at closing. Wilson Sonsini Goodrich & Rosati advised Arcellx on the transaction.
News Articles
1.29.26
2026 WTR 1000 Honors Wilson Sonsini’s Trademark Practice, Attorneys
Wilson Sonsini Goodrich & Rosati’s trademark and advertising practice has been ranked among the leading firms in the 2026 edition of World Trademark Review’s WTR 1000, an annual guide that showcases the top trademark professionals across key jurisdictions worldwide. The firm is recognized as a leader in both California and Washington.
Newsletters
1.08.26
Litigation Trends to Watch in 2026
Entering 2026, Wilson Sonsini litigators see a landscape defined by AI driven disputes, continued tightening of patent review standards, renewed securities and governance litigation, stronger consumer and influencer enforcement, and escalating Telephone Consumer Protection Act (TCPA) exposure—trends that require companies to align legal strategy with technical and operational controls.
Client Highlights
11.17.25
Wilson Sonsini Advises Kura Oncology on Patent and Trademark Matters Related to KOMZIFTI’s FDA Approval
On November 13, 2025, Kura Oncology (Kura) and Kyowa Kirin announced that the U.S. Food and Drug Administration (FDA) has granted full approval for KOMZIFTI™ (ziftomenib). Wilson Sonsini Goodrich & Rosati advised Kura on patent and trademark matters.
News Articles
6.05.25
2025 Chambers USA Guide Recognizes Wilson Sonsini Practices, Attorneys
The 2025 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 39 geography-specific practice categories and named 86 Wilson Sonsini attorneys among the best in their fields. This year, the firm received three new practice area rankings, including in the Artificial Intelligence category, and four improved practice area rankings.
Client Highlights
2.12.25
Wilson Sonsini Advises Yext on Acquisition of Places Scout
On February 10, 2025, Yext, Inc., a leading digital presence platform for multi-location brands, announced its acquisition of Places Scout, an industry-leading local SEO and location intelligence platform. Places Scout delivers real-time, location-based insights to assess performance, track competitors, and optimize visibility across every major search channel. The acquisition strengthens Yext's ability to provide best-in-class competitive intelligence, benchmarking, and AI-powered insights. Wilson Sonsini Goodrich & Rosati advised Yext on the transaction.
News Articles
2.05.25
Wilson Sonsini’s Trademark Practice, Attorneys Recognized in 2025 World Trademark Review 1000
Wilson Sonsini Goodrich & Rosati’s trademark and advertising practice has been ranked in the 2025 edition of World Trademark Review’s WTR 1000, an annual guide that highlights the top trademark professionals in key jurisdictions worldwide. Wilson Sonsini is recognized as a leading firm in Washington.